Ishibashi, Keiichiro
Aoyama, Toru http://orcid.org/0000-0001-6803-3800
Kotaka, Masahito
Satake, Hironaga
Tsuji, Yasushi
Kataoka, Masato
Nakamura, Masato
Nagata, Naoki
Sakamoto, Junichi
Oba, Koji
Mishima, Hideyuki
Funding for this research was provided by:
Yakult Honsha
Article History
Received: 3 November 2020
Accepted: 12 January 2021
First Online: 8 February 2021
Compliance with ethical standards
:
: Hironaga Satake has received research funding from Ono Pharmaceutical Co. Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Sanofi Co., Ltd., and honoraria from Bayer Co., Ltd., Bristol-Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eli Lilly Japan Co., Ltd., Merck Bio Pharma Co., Ltd., MSD Co., Ltd., Ono Pharmaceutical Co., Ltd., Sanofi Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Co., Ltd. and Yakult Honsha Co., Ltd.